M28 Capital Management LP
STAMFORD, CT
$47m in 9 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 10.5% of the portfolio this quarter.
Value
$47m
Stocks
9
Top 10 share
100.0%
Turnover
10.5%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Wave Life SciencesWVE | 56.5% | $27m | 4,588,284 | Held |
| InvivydIVVD | 17.1% | $8m | 9,248,250 | Held |
| TG TherapeuticsTGTX | 10.3% | $5m | 88,354 | Held |
| Arrowhead PharmaceuticalsARWR | 6.4% | $3m | 36,851 | Held |
| Fractyl HealthGUTS | 3.1% | $1m | 1,856,117 | Held |
| ProQR TherapeuticsPRQR | 2.4% | $1m | 599,793 | Held |
| Silence TherapeuticsSLN | 2.4% | $1m | 101,203 | Held |
| Rocket PharmaceuticalsRCKT | 1.5% | $721,179 | 210,871 | Held |
| CurisCRIS | 0.3% | $148,741 | 284,889 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is down 19.6% since 30 June 2025.
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.